Q2 2014 Holdings
Filed 2014-08-14 | 64 holdings | $301.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec Inc(BIIB) | COMMON | 09062X103 | $177.0M | 561,379 | 58.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COMMON | 09061G101 | $72.7M | 1,168,504 | 24.1% |
| Align Tech Inc(ALGN) | COMMON | 016255101 | $16.5M | 294,356 | 5.5% |
| Abbvie Inc(ABBV) | COMMON | 00287Y109 | $15.3M | 271,741 | 5.1% |
| Boston Scientific(BSX) | COMMON | 101137107 | $13.3M | 1,043,587 | 4.4% |
| Accuray Inc(ARAY) | COMMON | 004397105 | $4.3M | 491,505 | 1.4% |
| Amgen Inc(AMGN) | COMMON | 031162100 | $141.5K | 1,195,165 | 0.0% |
| Gilead Sciences Inc(GILD) | COMMON | 375558103 | $124.3K | 1,499,116 | 0.0% |
| Celgene Corp(CELG) | COMMON | 151020104 | $107.4K | 1,250,672 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COMMON | 92532F100 | $102.2K | 1,079,464 | 0.0% |
| Incyte Corporation(INCY) | COMMON | 45337C102 | $88.7K | 1,571,452 | 0.0% |
| Teva Pharmaceutical(TEVA) | ADR | 881624209 | $79.3K | 1,512,587 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COMMON | 015351109 | $76.4K | 489,108 | 0.0% |
| Mylan Inc | COMMON | 628530107 | $76.3K | 1,479,982 | 0.0% |
| Actavis PLC | SHARES | G0083B108 | $75.7K | 339,450 | 0.0% |
| Regeneron Pharmctcls(REGN) | COMMON | 75886F107 | $64.4K | 227,900 | 0.0% |
| Keryx Biopharmaceuticals Inc | COMMON | 492515101 | $57.5K | 3,741,656 | 0.0% |
| Shire PLC | SP ADR | 82481R106 | $54.3K | 230,636 | 0.0% |
| Synageva Biopharma | COMMON | 87159A103 | $54.1K | 516,445 | 0.0% |
| NPS Pharmaceuticals | COMMON | 62936P103 | $52.2K | 1,580,094 | 0.0% |
| Thermo Fisher Scientific(TMO) | COMMON | 883556102 | $52.0K | 440,300 | 0.0% |
| Theravance Inc | COMMON | 88338T104 | $51.9K | 1,743,188 | 0.0% |
| Perrigo Co(PRGO) | SHARES | G97822103 | $51.2K | 351,368 | 0.0% |
| Illumina Inc(ILMN) | COMMON | 452327109 | $44.1K | 246,789 | 0.0% |
| Halozyme Therapeutics(HALO) | COMMON | 40637H109 | $43.4K | 4,389,682 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMMON | 69366J200 | $40.6K | 1,551,274 | 0.0% |
| Portola Pharmaceuticals | COMMON | 737010108 | $39.8K | 1,365,152 | 0.0% |
| Insmed Inc(INSM) | COMMON | 457669307 | $39.7K | 1,985,738 | 0.0% |
| Mallinckrodt PLC | SHARES | G5785G107 | $38.5K | 481,564 | 0.0% |
| Immunogen Inc(IMGNEUR) | COMMON | 45253H101 | $38.1K | 3,218,276 | 0.0% |
| Merck & Co Inc(MRK) | COMMON | 58933Y105 | $37.9K | 654,582 | 0.0% |
| Allergan Inc | COMMON | 018490102 | $32.5K | 192,050 | 0.0% |
| Oncomed Pharmaceuticals | COMMON | 68234X102 | $32.4K | 1,392,485 | 0.0% |
| Sagent Pharmaceuticals | COMMON | 786692103 | $27.4K | 1,059,306 | 0.0% |
| Akorn Inc(AKRXEUR) | COMMON | 009728106 | $25.3K | 759,643 | 0.0% |
| Seattle Genetics Inc | COMMON | 812578102 | $23.4K | 612,219 | 0.0% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $22.0K | 509,917 | 0.0% |
| Valeant Pharmaceuticals Intl | COMMON | 91911K102 | $21.3K | 168,900 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COMMON | 60877T100 | $20.2K | 1,674,140 | 0.0% |
| Acceleron Pharma(XLRN) | COMMON | 00434H108 | $20.0K | 589,053 | 0.0% |
| Covidien PLC | SHARES | G2554F113 | $19.7K | 218,422 | 0.0% |
| Intercept Pharmaceuticals(ICPTUSD) | COMMON | 45845P108 | $17.5K | 73,993 | 0.0% |
| Relypsa Inc | COMMON | 759531106 | $17.3K | 712,973 | 0.0% |
| United Therapeutics(UTHR) | COMMON | 91307C102 | $16.1K | 182,400 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COMMON | 46120E602 | $16.1K | 38,983 | 0.0% |
| Chimerix Inc(CMRXEUR) | COMMON | 16934W106 | $13.9K | 631,894 | 0.0% |
| Clovis Oncology(CLVSEUR) | COMMON | 189464100 | $13.0K | 314,952 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COMMON | 48576U106 | $12.5K | 268,540 | 0.0% |
| Dexcom Inc(DXCM) | COMMON | 252131107 | $11.4K | 287,471 | 0.0% |
| Tornier N V | SHS | N87237108 | $11.2K | 477,829 | 0.0% |